Literature DB >> 11297035

Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel.

A Hermann1, B H Rauch, M Braun, K Schrör, A A Weber.   

Abstract

This study compares the subcellular localization and the regulation of expression of the platelet activation markers CD62P and CD63 with CD40 ligand (CD40L) on the surface of washed human platelets. CD40L was expressed upon stimulation with a wide range of platelet activators. However, quantitative flow cytometry demonstrated that, as compared with CD62P and CD63, CD40L expression was low. Upon stimulation with thrombin receptor-activating peptide (TRAP-6), all activation markers were expressed. In contrast, upon stimulation with low concentrations of collagen (1-3 microg/ml), CD40L, but not the granule proteins (CD62P, CD63), were expressed. Using immunofluorescence microscopy, a cytoplasmic staining was observed for CD40L, and cytoplasmic localization of CD40L was verified by Western blotting of subcellular platelet fractions. The staining of CD40L was different from that of filamentous actin and only little association of CD40L with platelet cytoskeleton was found. Surface expression of CD40L was dependent on internal Ca2+ stores and protein kinase C, while the mitogen-activated protein kinases (ERK, p38) or tyrosine kinases were not involved. ADP (30 microM)-induced CD40L expression was not inhibited by aspirin. In contrast, clopidogrel treatment completely abolished ADP-induced expression of CD40L. Finally, the expression level of CD40L was shown to be upregulated by phorbol myristate acetate (PMA) in the promegakaryocytic cell line MEG-01.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297035     DOI: 10.1080/09537100020031207

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  39 in total

Review 1.  Inflammation and atherosclerosis.

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

2.  Functional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 molecules.

Authors:  Youssef El Fakhry; Haydar Alturaihi; Daniel Yacoub; Lihui Liu; Wenyan Guo; Claire Leveillé; Daniel Jung; Lara Bou Khzam; Yahye Merhi; John A Wilkins; Hongmin Li; Walid Mourad
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

Review 3.  Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Guido R Y De Meyer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

Review 4.  [Haemostaseology].

Authors:  K Schrör
Journal:  Internist (Berl)       Date:  2005-08       Impact factor: 0.743

Review 5.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 6.  CD40/CD40L system and vascular disease.

Authors:  F Santilli; S Basili; P Ferroni; G Davì
Journal:  Intern Emerg Med       Date:  2007-11-28       Impact factor: 3.397

Review 7.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

8.  Premature labor: a state of platelet activation?

Authors:  Offer Erez; Roberto Romero; Debra Hoppensteadt; Jawed Fareed; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Nandor Gabor Than; Edi Vaisbuch; Chong Jai Kim; Jimmy Espinoza; Pooja Mittal; Neil Hamill; Chia-Ling Nhan-Chang; Moshe Mazor; Sonia Hassan
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

Review 9.  Platelet receptors and signaling in the dynamics of thrombus formation.

Authors:  José Rivera; María Luisa Lozano; Leyre Navarro-Núñez; Vicente Vicente
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

10.  AICAR reduces the collagen-stimulated secretion of PDGF-AB and release of soluble CD40 ligand from human platelets: Suppression of HSP27 phosphorylation via p44/p42 MAP kinase.

Authors:  Masanori Tsujimoto; Haruhiko Tokuda; Gen Kuroyanagi; Naohiro Yamamoto; Shingo Kainuma; Rie Matsushima-Nishiwaki; Takashi Onuma; Yuko Iida; Akiko Kojima; Shigenobu Sawada; Tomoaki Doi; Yukiko Enomoto; Kumiko Tanabe; Shigeru Akamatsu; Hiroki Iida; Shinji Ogura; Takanobu Otsuka; Osamu Kozawa; Toru Iwama
Journal:  Exp Ther Med       Date:  2016-06-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.